NCT00810602
Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant No drug interventions treatment 1 / 2 completed NCT00689884
Feasibility and Cost Analysis of PBSC Mobilization Using Pegfilgrastim in Hematologic Malignancies No drug interventions treatment Not Available terminated NCT01053884
Anidulafungin in Patients With Hematologic Malignancies No drug interventions prevention 2 terminated NCT02343679
Novartis PhII Ceritinib (LDK378) in R/R ALK+ Hem Malignancies No drug interventions treatment 2 withdrawn NCT00514579
Adult Double Cord Blood Transplant Study No drug interventions treatment 2 completed NCT00429143
A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative No drug interventions treatment 1 / 2 completed NCT04581187
An Online-platform to Improve Patient-centered Care During the COVID-19 Pandemic: a GIMEMA Surveillance Program in Hematologic Malignancies No drug interventions Not Available Not Available recruiting NCT01882387
Efficacy Study of a TXA127 to Reduce Graft-vs-Host Disease in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation supportive_care 2 withdrawn NCT06455553
Interpretability of the Quantra® Viscoelastic Test in Patients With Haematological Malignancies With Profound Thrombocytopenia Below 50x10 G/L. No drug interventions screening Not Available recruiting NCT00843947
Reduced Intensity Stem Cell Transplantation (RIST) for Patients With Hematological Malignancies Conditioned With Fludarabine and Busulfan No drug interventions treatment 2 completed NCT01949545
Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment other 1 completed NCT01260545
Study of CA-18C3 in Subjects With Advanced Hematologic Malignancies No drug interventions supportive_care 1 completed NCT04546945
Aberrant Expression of CD56 in Patients With Hematologic Malignancies. No drug interventions Not Available Not Available recruiting NCT01351545
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) No drug interventions Not Available Not Available recruiting NCT00731705
In-Vitro Studies in Depletion of Haplotype Mismatched Alloreactive T Cells No drug interventions Not Available Not Available withdrawn NCT02835911
Clinical Cohort of Lymphoma Patients in Malawi No drug interventions Not Available Not Available recruiting NCT04728893
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003) treatment 2 recruiting NCT01749293
Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation treatment 2 terminated NCT04098393
Giving Chemotherapy for a Shortened Amount of Time Before a Stem Cell Transplantation treatment 1 active_not_recruiting NCT00722488
Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma treatment 1 completed NCT05849207
Post-Transplant Cyclophosphamide in Patients Aged >/= 65 Years Undergoing Haploidentical Transplant treatment 1 recruiting NCT00231309
Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT) treatment Not Available completed NCT03082209
A Study of the Safety and Tolerability of ABBV-621 in Participants With Previously-Treated Solid Tumors and Hematologic Malignancies treatment 1 completed NCT00780052
Infusional C-myb ASODN in Advanced Hematologic Malignancies No drug interventions treatment 1 completed NCT00521859
Cloretazine (VNP40101M) With Hematopoietic Cell Transplantation for Hematologic Malignancies treatment 1 completed NCT00677859
Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia supportive_care 1 completed NCT02487459
Safety Study of Gene Modified Donor T-Cells in Adults With Advanced Hematologic Malignancies treatment 1 withdrawn NCT03320642
GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease prevention 1 terminated NCT00477542
A Phase I Trial of Myeloablative Conditioning w/ Clofarabine and HD Busulfan for Pts w/ Refractory Heme Malignancies Undergoing Allo PBSCT treatment 1 completed NCT04538599
RD13-01 for Patients With r/r CD7+ T/NK Cell Hematologic Malignancies No drug interventions treatment 1 completed NCT01316549
Study of Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation Not Available Not Available completed NCT02663518
A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors treatment 1 terminated NCT03557619
A Study to Assess the Effect of Venetoclax on Ethinyl Estradiol and Levonorgestrel in Female Participants With Different Hematological Malignancies basic_science 1 recruiting NCT01345019
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma supportive_care 3 completed NCT02160041
BGJ398 for Patients With Tumors With FGFR Genetic Alterations treatment 2 terminated NCT01010217
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide treatment 2 completed NCT00202917
Haploidentical Transplantation With CD3/CD19 Depleted Grafts in Patients With Hematologic Malignancies treatment 1 / 2 completed NCT02354417
A Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic Malignancies No drug interventions treatment 1 terminated NCT01881334
Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants No drug interventions Not Available Not Available available NCT04478916
Impact of the Comprehensive Geriatric Assessment on the Quality of Life OF Elderly Patients No drug interventions Not Available Not Available unknown_status NCT01328496
Umbilical Cord Blood Transplantation In Patients With Hematologic Malignancies Using A Myeloablative Preparative Regimen No drug interventions treatment 2 completed NCT05808296
The Effect of Lavender Oil on Fatigue and Sleep Quality No drug interventions supportive_care Not Available recruiting NCT00953758
A Study Of PF-04449913 In Select Hematologic Malignancies treatment 1 completed NCT02494258
A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders treatment 2 active_not_recruiting NCT00993486
Dose-ranging Study of a Single Administration of T-cell Add-back Depleted of Host Alloreactive Cells in Patients Undergoing a Peripheral Blood Stem Cell Transplant From a Related, Haploidentical Donor No drug interventions prevention 1 / 2 completed NCT02623439
A Study of Haploidentical Bone Marrow Transplant for Patients With Hematologic Malignancies treatment 2 suspended NCT04588922
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies treatment 1 / 2 recruiting NCT00058825
Stem Cell Transplant for Hematologic Diseases treatment 1 / 2 terminated NCT02964325
Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia No drug interventions supportive_care Not Available terminated NCT00113048
Subcutaneously Administered CAMPATH in CD52 Expressing Hematologic Malignancies treatment 1 terminated NCT00506857
Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support treatment 1 / 2 completed NCT00369226
Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation prevention 1 / 2 completed NCT01300026
AMG 319 Lymphoid Malignancy FIH No drug interventions treatment 1 completed NCT01882374
Efficacy Study of a TXA127 to Reduce Acute Graft-vs-Host Disease in Subjects Undergoing Double Umbilical Cord Blood Transplantation supportive_care 2 withdrawn NCT00061620
Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic Malignancies treatment 1 completed NCT03537482
APG-2575 Study of Safety, Tolerability ,PK/PD in Patients With Hematologic Malignancies treatment 0 recruiting NCT00675831
Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies No drug interventions treatment 1 completed NCT03486873
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587) treatment 3 recruiting NCT03609827
Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients Not Available Not Available completed NCT03212560
Exercise Capacity and Physical Activity Levels in Newly Diagnosed Hematologic Malignant Patients No drug interventions Not Available Not Available completed NCT05470491
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies in People Living With HIV treatment 1 / 2 suspended NCT02046291
Safety of Romiplostim (Nplate®) Following UCBT supportive_care 1 completed NCT02139280
Cyclophosphamide for Hematopoietic Stem Cell Mobilization in Patients With a Hematologic Malignancy treatment 2 completed NCT00469729
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy treatment 2 / 3 completed NCT03609840
Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients No drug interventions Not Available Not Available completed NCT06296368
DISCOVERY: Evaluating a Decision Support Tool for Adults Seen in Hematology/Oncology Clinics No drug interventions health_services_research Not Available not_yet_recruiting NCT01844869
An Open-Label Study to Investigate the Pharmacokinetics of Omacetaxine Mepesuccinate No drug interventions treatment 1 completed NCT02032446
Umbilical Cord Derived Mesenchymal Stromal Cells For The Treatment of Severe Steroid-resistant Graft Versus Host Disease No drug interventions treatment 1 / 2 unknown_status NCT00138112
Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation No drug interventions prevention 3 completed NCT04112810
Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease No drug interventions treatment 2 completed NCT01930981
Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life No drug interventions Not Available Not Available completed NCT00146614
Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation No drug interventions treatment 2 completed NCT00741455
Chemotherapy Followed by Allogeneic Stem Cell Transplantation for Hematologic Malignancies No drug interventions treatment Not Available completed NCT01351350
Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies No drug interventions treatment 1 completed NCT06378138
ICP-248 in Combination With Orelabrutinib in Treatment-naïve Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma No drug interventions treatment 2 / 3 recruiting NCT00144703
Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation No drug interventions prevention 2 completed NCT02145403
Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies No drug interventions treatment 1 / 2 completed NCT05433090
An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies No drug interventions health_services_research Not Available recruiting NCT05724121
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax No drug interventions Not Available Not Available recruiting NCT01981187
LGX818 for Patients With BRAFV600 Mutated Tumors No drug interventions treatment 2 terminated NCT06465433
Extension Study to Provide Continued Treatment for Patients With Hematologic Malignancies Previously Enrolled in Studies With Tafasitamab No drug interventions treatment 2 recruiting NCT02503033
A Study of HMPL-523 in Relapsed or Refractory Hematologic Malignancies No drug interventions treatment 1 unknown_status NCT05371054
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies No drug interventions treatment 1 / 2 recruiting NCT02985554
Phase I Study to Assess the Tolerability and Efficacy of Nivolumab in Patients With Hematologic Malignancies No drug interventions treatment 1 terminated NCT02743351
Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies No drug interventions prevention 1 / 2 completed NCT01788605
Efficacy Study of Ramosetron in the Setting of Hematopoietic Stem Cell Transplantation No drug interventions supportive_care 2 unknown_status NCT01081405
Total Lymphoid Irradiation and Anti-Thymocyte Globulin in the Allogeneic Hematopoietic Cell Transplantation No drug interventions treatment Not Available completed NCT02786628
Assessing Physical Fitness in Cancer Patients With Cardiopulmonary Exercise Testing and Wearable Data Generation No drug interventions Not Available Not Available completed NCT06028828
Risk-ADAPTed Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions treatment 2 recruiting NCT02118311
Treg Cells for AGVHD in Non-myeloablative UCB Transplant No drug interventions supportive_care 2 withdrawn NCT02709993
Consolidation Therapy in Patients With Hematologic Malignancies No drug interventions treatment 1 / 2 withdrawn NCT04214093
A Study of AZD0466 in Patients With Advanced Hematologic or Solid Tumors No drug interventions treatment 1 terminated NCT05028478
A Study of CN202 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors or Hematologic Malignancies No drug interventions treatment 1 / 2 unknown_status NCT01810588
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation No drug interventions treatment 2 active_not_recruiting NCT00189488
Trial to Evaluate Palifermin in the Reduction of Acute Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Allogeneic Marrow/Peripheral Blood Progenitor Cell (PBPC) Transplantation No drug interventions treatment 2 completed NCT00355407
Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation No drug interventions treatment Not Available completed NCT01186809
Cytokine Induced Killer (CIK) Cells In Leukemia Patients No drug interventions treatment 2 completed NCT04696809
A Study of Teclistamab in Japanese Participants With Relapsed or Refractory Multiple Myeloma No drug interventions other 1 / 2 active_not_recruiting NCT01380756
Study Evaluating Orally Administered AMG 900 in Adult Subjects With Acute Myeloid Leukemia No drug interventions treatment 1 completed NCT01622556
Conditioning Treatment With Umbilical Cord Blood Transplant for Hematologic Malignancies No drug interventions treatment 2 terminated NCT02921685
Study of a Humanized Antibody Initiated 2 Months After an HLA Matched Allogenic Stem Cell Transplantation No drug interventions treatment 1 unknown_status NCT02492737
Study of Orally Administered AG-881 in Patients With Advanced Hematologic Malignancies With an IDH1 and/or IDH2 Mutation No drug interventions treatment 1 completed NCT00750737
Oral Posaconazole Three Times Per Day vs Weekly High Dose Amphotericin B Lipid Complex (ABLC) No drug interventions treatment 3 completed NCT02386332
A Randomized Multicenter Study to Compare Two Types of Transplant in Adult Patients With Hematologic Malignancies No drug interventions Not Available Not Available unknown_status NCT00890500
Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies. No drug interventions treatment 1 completed NCT02844400
Cancer Patients' Performance Status Assessed Using Cardiopulmonary Exercise Testing and Wearable Data Generation No drug interventions Not Available Not Available completed NCT02884375
Elderly CAncer Patient No drug interventions Not Available Not Available recruiting NCT05104775
A Study of GNC-035, a Tetra-specific Antibody, in Participants With Relapsed/Refractory Hematologic Malignancy No drug interventions treatment 1 recruiting NCT01484470
Umbilical Cord Transplantation for the Elderly Population No drug interventions treatment 2 completed NCT04758442
Optimal Dosing of Vancomycin in an Adult Population of Hemato-oncology No drug interventions basic_science Not Available unknown_status NCT01375842
A Study of Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors No drug interventions treatment 1 completed NCT02315599
Follow-Up Evaluation for Gene-Therapy-Related Delayed Adverse Events After Participation in Pediatric Oncology Branch Clinical Trials No drug interventions Not Available Not Available enrolling_by_invitation NCT00596999
A Single-arm Safety Study of Transplantation Using Umbilical Cord Blood and Human Placental-derived Stem Cells From Partially Matched Related Donors in Persons With Certain Malignant Blood Diseases and Non-malignant Disorders No drug interventions Not Available Not Available unknown_status NCT00228813
G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome No drug interventions treatment Not Available terminated NCT02342613
Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation No drug interventions treatment 1 completed NCT04428918
Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation No drug interventions Not Available Not Available withdrawn NCT05923541
RD13-02 for Patients With r/r CD7+ T Cell Hematologic Malignancies No drug interventions treatment 0 recruiting NCT00741234
A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine No drug interventions treatment 1 completed NCT01551524
Phase I Study of mPEG-R-Crisantaspase Given IV No drug interventions treatment 1 completed NCT00429416
Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation No drug interventions treatment 1 / 2 completed NCT01350258
Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps No drug interventions treatment 1 / 2 terminated NCT00824135
Haploidentical Hematopoietic Stem Cell Transplantation Using A Novel Clofarabine Containing Conditioning Regimen For Patients With Refractory Hematologic Malignancies No drug interventions treatment 1 completed NCT01237639
Study of Red Blood Cell Transfusion Triggers in Patients Undergoing Hematopoietic Stem Cell Transplantation No drug interventions supportive_care 3 completed NCT01725022
A Controlled Study of Stem Cell Transplantation Medical Home Care Compared to Standard Hospital Care No drug interventions health_services_research Not Available completed NCT01912222
Pharmacokinetic Study of Oral IXAZOMIB in Cancer Patients With Liver Dysfunction No drug interventions treatment 1 completed NCT01203722
Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies No drug interventions treatment 1 / 2 recruiting NCT00086125
Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED) No drug interventions treatment 2 completed NCT02473757
Gene Therapy Follow-up Protocol for People Previously Enrolled in CAR-T Cell Studies No drug interventions Not Available Not Available enrolling_by_invitation NCT04263857
Register of Blood Stem Cell Transplantation No drug interventions Not Available Not Available recruiting NCT01476657
A Phase 1 Study of Duvelisib in Patients With Advanced Hematologic Malignancies No drug interventions treatment 1 terminated NCT02988466
Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT No drug interventions treatment 2 active_not_recruiting NCT02301065
Analysis of T Cell and Natural Killer (NK) Cell in Relation to Viral Infections in Pediatric Stem Cell Transplant Patients and Donors No drug interventions Not Available Not Available completed NCT00660920
Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies No drug interventions treatment 1 completed NCT01460420
Sequential Trial on Reduced Intensity Conditioning (RIC) Allogeneic Transplantation No drug interventions treatment 1 / 2 completed NCT02129582
Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies No drug interventions treatment 1 completed NCT00642031
Triciribine Phosphate Monohydrate (TCN-PM, VD-0002) in Adult Patients With Advanced Hematologic Malignancies No drug interventions treatment 1 completed NCT01687231
Infection Rates of Myeloablative Allo SCT Recipients Receiving Neutropenic Diets Versus Non-Neutropenic Diets No drug interventions prevention Not Available completed NCT00693927
Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC) No drug interventions treatment 2 completed NCT00079391
Stem Cell Transplantation and T-Cell Add-Back to Treat Bone Marrow Malignancies No drug interventions treatment 2 completed NCT01193491
Dose Escalation of IPI-493 in Hematologic Malignancies No drug interventions treatment 1 terminated NCT02457962
Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study No drug interventions Not Available Not Available recruiting NCT02758080
Matching Patients With Hematologic Malignancy to Adequate Clinical Trials No drug interventions treatment Not Available unknown_status NCT00496340
Phase II Trial of Pentostatin and Targeted Busulfan No drug interventions treatment 2 completed NCT00881946
Repeat Dose Safety Study for Compound to Treat Hematologic Cancer No drug interventions basic_science 1 / 2 completed NCT02223312
Therapy for Progressive and/or Refractory Hematologic Malignancies No drug interventions treatment 1 / 2 withdrawn NCT00402714
A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies No drug interventions treatment 2 completed NCT01627314
The PUMA Trial is a Trial of a Single ProHema Modulated-Cord Blood (CB) Unit as Part of a Double CB Transplant in Patients With Hematologic Malignancies. No drug interventions treatment 2 terminated NCT03609814
Study of Clofarabine and Fludarabine Drug Exposure in Pediatric Bone Marrow Transplantation (HCT) No drug interventions Not Available Not Available completed NCT00042250
IUdR/BUdR Cell Cycle Labelling No drug interventions diagnostic Not Available completed NCT01217723
Thymoglobulin in Unrelated Hematopoietic Progenitor Cell Transplantation No drug interventions prevention 3 unknown_status NCT00770523
Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells No drug interventions Not Available Not Available completed NCT00208923
Allogeneic Bone Marrow Transplantation With Matched Unrelated Donors for Patients With Hematologic Malignancies No drug interventions treatment 2 completed NCT02600208
Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies With Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device No drug interventions treatment 2 / 3 active_not_recruiting NCT00405743
A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies No drug interventions treatment 1 / 2 completed NCT03806764
Cytomegalovirus (CMV) Reactivation in Allogeneic HSCT Recipient No drug interventions diagnostic Not Available enrolling_by_invitation NCT04174053
Concordance Between 2 Means of Temperature Measure in Neutropenic Patients Hospitalized in Intensive Hematology Care Units No drug interventions other Not Available unknown_status NCT05159245
The Finnish National Study to Facilitate Patient Access to Targeted Anti-cancer Drugs treatment 2 recruiting NCT04673305
Cognitive Status Assessment In Elderly Patients With Active Treatment For Haematological Malignancies No drug interventions diagnostic Not Available unknown_status NCT04331483
A Study to Assess a Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Allografts No drug interventions supportive_care Not Available withdrawn NCT06510699
Pharmacogenomics for Better Treatment of Fungal Infections in Cancer No drug interventions treatment 2 not_yet_recruiting NCT05460013
Impact of Oral Nutritional Supplements on Patients Undergoing Haematopoietic Stem Cell Transplantation No drug interventions supportive_care Not Available recruiting NCT04236063
Rehabilitation Needs of the Malaysian Haematological Cancer Survivors No drug interventions Not Available Not Available completed NCT05298930
Feasibility Study to Assess an Adapted Physical Activity Program in Children, Adolescents and Young Adults Requiring Hematopoietic Stem Cell Transplantation No drug interventions supportive_care Not Available completed NCT03262220
Total Marrow Irradiation With Volumetric Arc Therapy for Patients Unfit for a 12 Gy TBI No drug interventions treatment Not Available recruiting NCT06395220
Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available recruiting NCT03750994
Economic Evaluation of Innovative Molecular Analyses in Onco-haematology No drug interventions Not Available Not Available unknown_status NCT03688789
Hématologie Adulte Prevalence of Adrenal Insufficiency Post-chemotherapy Adrenocorticotropia in Adult Hematology No drug interventions diagnostic Not Available withdrawn NCT05352789
Nutrition and Metabolic Prehabilitation in HSCT Patients UK and ROI. BSBMT Multi-centre Survey. No drug interventions Not Available Not Available completed NCT03146468
Nivolumab for Relapsed or Residual Haematological Malignancies After Allogeneic Stem Cell Transplantation No drug interventions treatment 2 unknown_status NCT05379738
Impact of Adapted Physical Activity on Patient's Recovery Following Allogeneic Stem Cell Transplantation for Hematological Malignancy No drug interventions basic_science Not Available recruiting NCT05678621
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension No drug interventions treatment 2 / 3 recruiting NCT05170347
oGVHD After Bone Marrow Transplantation: a Territory-wide Cohort No drug interventions Not Available Not Available recruiting NCT04397705
Remote Monitoring of Cancer Patients With Suspected Covid-19 No drug interventions other 1 unknown_status NCT04068597
Study to Evaluate CCS1477 in Haematological Malignancies No drug interventions treatment 1 / 2 recruiting NCT05768178
DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers. No drug interventions treatment 2 / 3 recruiting NCT05203809
Continuous Temperature Monitoring for tHe Early Recognition of Febrile Neutropenia in Haematological MALignancies No drug interventions Not Available Not Available unknown_status NCT05770037
DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Teenage/Young Adults (TYA) and Paediatric Patients With ALK Positive Cancers No drug interventions treatment 2 / 3 recruiting NCT05786716
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutations No drug interventions treatment 2 / 3 recruiting NCT05722886
DETERMINE (Determining Extended Therapeutic Indications for Existing Drugs in Rare Molecularly Defined Indications Using a National Evaluation Platform Trial) - Master Screening Protocol No drug interventions treatment 2 / 3 recruiting NCT06481527
Seen and Be Heard: Ensuring Fair Cancer Care for All Children No drug interventions Not Available Not Available not_yet_recruiting NCT04298892
Integrated Multiomics and Multilevel Characterization of Haematological Disorders and Malignancies No drug interventions Not Available Not Available recruiting NCT05770544
DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Teenage/Young Adults and Paediatric Patients With ROS1 Gene Fusion-positive Cancers. No drug interventions treatment 2 / 3 recruiting NCT03855969
Central Venous Access Device Removal in Cancer Patients No drug interventions Not Available Not Available completed NCT03978312
Nutrition Health Literacy of Cancer Patients and Their Support Networks. No drug interventions Not Available Not Available terminated NCT05695638
Proseq Cancer: Genomic Profiling in Patients With Incurable Cancer in Search for Targeted Treatment No drug interventions Not Available Not Available recruiting NCT01080664
A Phase I, Dose-escalation Study of AS703569 Given Orally to Subjects With Haematological Malignancies No drug interventions treatment 1 terminated NCT01827579
Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT) No drug interventions prevention 1 / 2 completed NCT04865419
Study of AZD0466 Monotherapy or in Combination in Patients With Advanced Haematological Malignancies treatment 1 terminated NCT01336478
CD56+CD3- NK Cells Following Allogeneic Stem Cell Transplantation No drug interventions treatment 1 withdrawn NCT05148806
Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies No drug interventions Not Available Not Available completed NCT01719341
Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia No drug interventions Not Available Not Available unknown_status NCT02988258
Study of Adoptive Immunotherapy With Donor-derived CMV-specific T Cells for Recipients of Allo-HSCT No drug interventions treatment 1 suspended NCT05391490
Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ Malignancies No drug interventions treatment 1 not_yet_recruiting NCT01957579
A Phase 1, Dose-escalation Study of MEDI-551 in Japanese Adult Patients With Relapsed or Refractory Advanced B-cell Malignancies No drug interventions treatment 1 completed NCT05190653
Early Integration of Palliative and Supportive Care in Cellular Therapy No drug interventions supportive_care Not Available recruiting NCT05873205
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation treatment 2 recruiting NCT06469307
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE) No drug interventions Not Available Not Available not_yet_recruiting NCT04737785
Central Nervous System Disorders Following Hematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available completed NCT06119685
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers treatment 1 / 2 recruiting NCT06116032
Immune Profiling for Cancer Immunotherapy Response No drug interventions Not Available Not Available recruiting NCT04466059
Better Leukemia Diagnostics Through AI (BELUGA) No drug interventions Not Available Not Available recruiting NCT04390542
Intervention for Caregivers of Patients Undergoing HSCT or CAR T-cell Therapy No drug interventions supportive_care Not Available withdrawn NCT05692713
Polyomic Biomarker Verification in Adult Chronic Graft-Versus-Host Disease (ABLE3.0/CTTC2201) No drug interventions Not Available Not Available recruiting NCT00185796
TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD No drug interventions treatment 2 completed NCT05709522
Neurocognitive and Psychosocial Outcomes Among Pediatric Brain Tumor and Blood Cancer Patients No drug interventions Not Available Not Available recruiting NCT00186225
Stem Cell Transplant From Matched Unrelated or Partially Matched Related Donors No drug interventions treatment Not Available completed NCT06168825
Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention No drug interventions Not Available Not Available active_not_recruiting NCT06455592
Effect of APA on Sleep Quality in Children With Cancer From 5 to 16 Years No drug interventions prevention Not Available not_yet_recruiting NCT00185640
Allogeneic Transplantation Using Total Lymphoid Irradiation (TLI) and Anti-Thymocyte Globulin (ATG) for Older Patients With Hematologic Malignancies No drug interventions treatment 2 completed NCT02361346
Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL No drug interventions treatment 1 / 2 terminated NCT06250595
European Rare Blood Disorders Platform (ENROL) No drug interventions Not Available Not Available recruiting NCT00185614
Non-myeloablative Allogeneic Transplantation for the Treatment of Multiple Myeloma No drug interventions treatment 2 completed NCT06574308
Clinical Evaluation of the Scopio Cell Morphology Technology No drug interventions Not Available Not Available not_yet_recruiting NCT04955938
A Study of Fedratinib With IDH Inhibition in Advanced-Phase, IDH-Mutated Ph-Negative Myeloproliferative Neoplasms No drug interventions treatment 1 withdrawn NCT00230321
A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS) No drug interventions treatment 1 / 2 completed NCT05147311
Positive Psychology Intervention In HSCT No drug interventions supportive_care Not Available completed NCT06543511
MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies No drug interventions health_services_research Not Available not_yet_recruiting NCT04188678
Resiliency in Older Adults Undergoing Bone Marrow Transplant No drug interventions other Not Available active_not_recruiting NCT06482515
Take the Reins: The Effects of Nutrient Timing on Cancer-related Fatigue No drug interventions supportive_care 2 not_yet_recruiting NCT06582849
Enhanced Assistance During Radiotherapy for Unmet Essential Needs No drug interventions health_services_research Not Available not_yet_recruiting NCT04372524
Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study No drug interventions Not Available Not Available recruiting NCT05646576
Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy No drug interventions supportive_care Not Available recruiting NCT00962494
Cancer: Thriving and Surviving Online Workshop and Study for Cancer Survivors No drug interventions supportive_care 2 completed NCT00185692
Allogeneic Transplantation From Related Haploidentical Donors No drug interventions treatment 2 completed NCT05450367
Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy. No drug interventions Not Available Not Available unknown_status NCT03654404
A Proof-of-Concept Trial of a Positive Psychology Intervention for Allogeneic Stem Cell Transplant Patients No drug interventions other Not Available completed NCT04806295
The Leukemia and Lymphoma Society (LLS) National Research Registry No drug interventions Not Available Not Available recruiting NCT04419623
A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer No drug interventions treatment 1 completed NCT00695279
Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products No drug interventions Not Available Not Available recruiting NCT05626764
QUALITOP - Monitoring Multidimensional Aspects of QUAlity of Life After Cancer ImmunoTherapy, an Open Smart Digital Platform for Personalized Prevention and Patient Management No drug interventions Not Available Not Available recruiting NCT05481502
An Exploratory Study to Evaluate Immune Determinants of the Response to Adoptive Cell Therapy (ACT) in Solid and Hematologic Tumors No drug interventions other Not Available recruiting NCT05375643
SURGE: Supporting UnderRepresented Minorities in Genomics-based Cancer Trial Enrollment (Intervention) No drug interventions health_services_research Not Available recruiting NCT05142033
Avera Cancer Sequencing and Analytics Protocol (ASAP) No drug interventions Not Available Not Available recruiting NCT03091933
Antiminor Histocompatibility Complex (MiHA) T Cells for Patients With Relapsed Hematologic Malignancies Following Matched HSCT (Guided Lymphocyte Immunopeptide Derived Expansion) No drug interventions treatment 1 / 2 unknown_status NCT04235153
CAncer, NUtrition and Taste - Validation of the CANUT-QVA Questionnaire on Eating Habits in Cancer Patients No drug interventions Not Available Not Available completed NCT05465577
Coverage and Cost-of-Care (CC) Links- Financial Navigation Program No drug interventions health_services_research Not Available completed NCT04035447
Symptom Management for YA Cancer Survivors No drug interventions supportive_care Not Available completed NCT06260111
Photobiomodulation for Oral Mucositis and Functional Impairments During Hematopoietic Stem Cell Transplantation No drug interventions prevention Not Available recruiting NCT05323409
Improving Comprehensive Care of Cancer Patients No drug interventions supportive_care Not Available recruiting NCT05942885
Hypnosis: a Path to Appeasement No drug interventions basic_science Not Available recruiting NCT05493800
Evaluate the Safety and Efficacy for Oral Mucositis Prevention of MIT-001 in Auto HSCT No drug interventions prevention 2 active_not_recruiting NCT05690230
Improving Patient Experience: BMBA No drug interventions supportive_care Not Available active_not_recruiting NCT01792882
Prospective Collection of Surplus Surgical Tumor Tissues and Pre-surgical Blood Samples No drug interventions Not Available Not Available withdrawn NCT03955276
An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme) No drug interventions Not Available Not Available terminated NCT05175508
Aza With or Without ATRA in Newly Diagnosed Unfit AML or Intermediate,High or Very High Risk MDS No drug interventions treatment 2 / 3 unknown_status NCT05061654
CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients No drug interventions treatment 4 withdrawn NCT05715047
Intervention for Fatigue in HCT Recipients No drug interventions supportive_care Not Available recruiting NCT04966156
Cancer Rehab Program for Allogenic Bone and Marrow Transplant Patients - CaRE-4-alloBMT No drug interventions supportive_care Not Available completed NCT06279585
Physical Therapy in Patients Undergoing Allo-HSCT With cGVHD No drug interventions treatment Not Available not_yet_recruiting NCT06377059
Early Detection of Complications During Immunotherapy for Haematological Malignancy No drug interventions diagnostic Not Available not_yet_recruiting NCT06053918
Research-Action in Hematology From Hospitalization to Home No drug interventions Not Available Not Available completed NCT04412135
The Point of View of Hematological Cancer Patients and Their Loved Ones Regarding Spirituality No drug interventions Not Available Not Available unknown_status NCT05866757
Discontinuation Study No drug interventions other Not Available recruiting NCT04822974
TORQUETENOVIRUS IN CAR-T THERAPY: PREDICTION OF THE CRS No drug interventions diagnostic Not Available unknown_status NCT00742560
A Phase 1b/2, Dose-Escalation Study of Elotuzumab (Humanized Anti-CS1 Monoclonal IgG1 Antibody) in Relapsed Multiple Myeloma No drug interventions treatment 2 completed NCT05753501
Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies No drug interventions treatment 1 recruiting NCT05602168
Collection of Sequential Samples From Patients With Malignant Myeloid Hemopathy for the Study of Treatment Resistance No drug interventions basic_science Not Available not_yet_recruiting NCT00504803
Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease No drug interventions prevention 2 completed NCT04959903
Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCT No drug interventions treatment 1 / 2 recruiting NCT00763490
Trial Of Double Umbilical Cord Blood Transplantation No drug interventions treatment 2 completed NCT00179764
Immunoablative Mini Transplant (Hematopoietic Peripheral Blood Stem Cell Transplant [HPBSC]) No drug interventions treatment Not Available completed NCT01139164
Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3) No drug interventions treatment 2 terminated NCT00379587
Rituximab for Prevention of Chronic GVHD prevention 1 / 2 completed NCT01069887
A Prospective Registry for Febrile Events in Patients With Malignant Hemopathies or Subjected to Haematopoietic Stem Cell Transplant No drug interventions Not Available Not Available completed NCT04790747
Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions No drug interventions treatment 1 / 2 recruiting NCT01063647
Dose-range Finding Treosulfan-based Conditioning treatment 1 / 2 completed NCT06238245
Combination of ATG-based Conditioning Regimen and PTCy for GVHD Prevention in Allo-HSCT After PD-1 Blockade prevention 2 not_yet_recruiting NCT05290545
Haplo-PBSC+Cord vs Haplo-PBSC+BM for Hematological Malignancies Undergoing Allo-HSCT No drug interventions treatment 3 completed NCT04260698
Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies treatment 3 active_not_recruiting NCT04557098
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma treatment 2 active_not_recruiting NCT06179511
Study of AZD9829 in CD123+ Hematological Malignancies No drug interventions treatment 1 / 2 recruiting NCT00824993
Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients treatment 3 completed NCT00500578
Intermittent Use of Aerosolized Ribavirin for Treatment of RSV treatment 4 completed NCT02828878
Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation No drug interventions treatment 1 / 2 unknown_status NCT04662788
Clinical Study on the Safety and Effectiveness of NK Cells/Combined Monoclonal Antibodies in the Treatment of Hematological Malignancies treatment 0 not_yet_recruiting NCT01821456
Cologne Cohort of Neutropenic Patients (CoCoNut) No drug interventions Not Available Not Available recruiting NCT02834156
Impact of Child Positioning on Pain During a Lumbar Puncture No drug interventions other Not Available completed NCT06041815
Correlation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological Malignancies No drug interventions Not Available Not Available recruiting NCT01315132
A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies No drug interventions treatment 2 completed NCT04634552
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma treatment 2 recruiting NCT05475600
APA and Relaxation by Biofeedback in Patients With Haematological Malignancy Admitted in ICU No drug interventions supportive_care Not Available recruiting NCT00348959
An Evaluation of the Effect of 'Open Window' on Psychological Well-being and Experience of Stem Cell Transplantation No drug interventions supportive_care Not Available completed NCT00382759
Nonmyeloablative Stem Cell Transplant in Elderly No drug interventions treatment 2 / 3 completed NCT02730299
Stem Cell Transplantation With NiCord® (Omidubicel) vs Standard UCB in Patients With Leukemia, Lymphoma, and MDS treatment 3 active_not_recruiting NCT03399799
Dose Escalation Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myeloma treatment 1 recruiting NCT01246206
Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT treatment 2 completed NCT02199041
Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen treatment 2 terminated NCT05454241
CD7 CAR-T for Patients With r/r CD7+ Hematologic Malignancies No drug interventions treatment 2 recruiting NCT00841724
Study of a Reduced-toxicity "Submyeloablative" Conditioning Regimen Prior to Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies treatment 2 completed NCT00423124
Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological Malignancies No drug interventions treatment 1 / 2 completed NCT02298816
B-Cell Hematologic Malignancy Vaccination Registry No drug interventions Not Available Not Available withdrawn NCT05728658
The Study of ICP-248 in Patients With Mature B-cell Malignancies No drug interventions treatment 1 recruiting NCT02611063
Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant treatment 1 completed NCT02849886
T Lymphocytes (LT) Expressing iCASP9 and ΔCD19 in Allogeneic Haematopoietic Transplantation. prevention 1 / 2 unknown_status NCT04878822
Immunogenicity of Covid-19 Vaccination for Patients With Hematological Malignancies No drug interventions Not Available Not Available unknown_status NCT02213822
Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis No drug interventions Not Available Not Available unknown_status NCT05347225
A Study of Nemtabrutinib (MK-1026) in China Participants With Relapsed or Refractory Hematologic Malignancies (MK-1026-005) treatment 1 active_not_recruiting NCT01816230
Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM treatment 1 / 2 completed NCT00876148
Risk of Hepatitis B Virus Reactivation in Patients Undergoing Allografting No drug interventions Not Available Not Available completed NCT02199548
The Good Patient Study No drug interventions Not Available Not Available completed NCT01916057
Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis No drug interventions diagnostic Not Available completed NCT00930566
Extracorporal Photopheresis Pilot Study prevention 1 / 2 unknown_status NCT04657965
LMP1 CAR-T for Patients With LMP1 Positive Infectious Diseases and Hematological Malignancies No drug interventions treatment 0 not_yet_recruiting NCT01168882
Safety and Tolerability of RGB-286638 in Patients With Selected, Relapsed or Refractory Hematological Malignancies No drug interventions treatment 1 withdrawn NCT03802773
Cord Blood Transplantation With Myeloablative Conditioning and Post-transplant Cyclophosphamide (COmPACt Study) No drug interventions Not Available Not Available recruiting NCT01060462
Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients No drug interventions Not Available Not Available completed NCT03236129
Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells No drug interventions treatment 3 recruiting NCT01607892
Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer No drug interventions treatment 1 completed NCT00163644
RCT to Investigate Whether an Exercise Programme Improves the Physical Performance and QOL After BMT No drug interventions treatment Not Available unknown_status NCT03733340
Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT No drug interventions prevention 2 / 3 unknown_status NCT01349101
A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors No drug interventions treatment 2 completed NCT00088101
STA-5312 Administered on Alternate Weekdays Every Two Weeks to Patients With Hematologic Malignancies and Patients With Solid Tumors No drug interventions treatment 1 completed NCT03711604
Compassionate Use Study of Tenalisib (RP6530) No drug interventions treatment 1 / 2 completed NCT04142372
Tissue Microarray of Hematological Malignancies No drug interventions Not Available Not Available active_not_recruiting NCT06150469
Efficacy of Inhaled Aromatherapy on Nausea and Vomiting in Hematological Malignancies No drug interventions prevention Not Available recruiting NCT02931110
Study of IV CBL0137 in Previously Treated Hematological Subjects No drug interventions treatment 1 terminated NCT03145181
Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma No drug interventions treatment 1 recruiting NCT01725555
A Study to Assess the Effect of Food on the Bioavailability of the IGF-1R Inhibitor AXL1717 in Patients With Advanced Malignant Tumors No drug interventions Not Available 1 completed NCT00129155
MiniMUD Study - Unrelated Reduced Intensity Conditioning With Treosulfan® for Allogeneic Stem Cell Transplantation in Patients With Hematological Malignancies No drug interventions treatment 2 unknown_status NCT00580450
Thymosin Alfa 1 in Recipients of Allogeneic Hematopoietic Transplantation for Hematological Malignancies No drug interventions treatment 1 / 2 unknown_status NCT00884364
Exercise During Chemotherapy for Patients With Hematological Malignancies No drug interventions Not Available 3 unknown_status NCT06550102
Drug Response Profiling (DRP) Registry Zurich for Hematological Malignancies No drug interventions Not Available Not Available recruiting NCT00506402
A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies No drug interventions treatment 1 completed NCT00892502
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy? No drug interventions treatment Not Available completed NCT00524784
Open-Label Study Designed to Evaluate the Safety and Preliminary Efficacy of ApoCell for the Prevention of Acute GvHD No drug interventions prevention 1 / 2 unknown_status NCT00788684
Safety Study of ABT-263 in Combination With Rituximab in Lymphoid Cancers No drug interventions treatment 1 active_not_recruiting NCT03248479
Magrolimab Monotherapy or Magrolimab in Combination With Azacitidine in Participants With Hematological Malignancies No drug interventions treatment 1 terminated NCT00603954
Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings No drug interventions treatment 2 completed NCT03344705
Safety and Efficacy Evaluation of IM19 Cells No drug interventions treatment 1 unknown_status NCT04283097
Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects No drug interventions treatment 1 recruiting NCT02300571
Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant No drug interventions Not Available Not Available unknown_status NCT00438178
Safety and Efficacy of Obatoclax Mesylate (GX15-070MS) for the Treatment of Hematological Malignancies No drug interventions treatment 1 completed NCT04743388
Study of the Kinetics of Antibodies Against COVID-19 (SARS-CoV-2) and of Cellular Subpopulations of the Immune System No drug interventions Not Available Not Available unknown_status NCT05306509
Nurse-initiated Conversations for Early Integration of Palliative Care in Pediatric Oncology No drug interventions supportive_care Not Available recruiting NCT04352556
COVID19-hematological Malignancies: the Italian Hematology Alliance No drug interventions Not Available Not Available unknown_status NCT01172132
The Use of Intensive Care in Critically Ill Cancer Haematological Patients: "TRIAL-OH" No drug interventions Not Available Not Available completed NCT02824159
Association Between Side Effects Occurrence and Concentrations of Ibrutinib and Idelalisib No drug interventions Not Available Not Available completed NCT01627275
Naive T-Cell Depleted DLI Following Allo Stem Cell Transplant No drug interventions treatment 1 completed NCT02215070
Pasireotide in Prevention of GI Toxicity No drug interventions treatment 2 completed NCT05005442
A Study of Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004) No drug interventions treatment 2 active_not_recruiting NCT03837899
Durvalumab and Tremelimumab for Pediatric Malignancies No drug interventions treatment 1 / 2 active_not_recruiting NCT06180499
Allogeneic Immunotherapy of Hematological Malignancies Using Regulatory T-cell Selective Depletion No drug interventions treatment 1 / 2 not_yet_recruiting NCT02074436
PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid) No drug interventions treatment 2 terminated NCT00838019
Intrabone Cord Blood Transplantation No drug interventions treatment 4 unknown_status NCT00557817
Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT) No drug interventions treatment 2 / 3 completed NCT02576496
Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies No drug interventions treatment 1 completed NCT01162096
Reduced Intensity Haploidentical Transplant for Hematological Malignancies No drug interventions treatment 1 / 2 completed NCT05768035
Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide No drug interventions treatment 1 / 2 recruiting NCT05020639
A Study of TQB3820 in Patients With Hematological Malignancies No drug interventions treatment 1 recruiting NCT00886522
Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies No drug interventions treatment 2 completed NCT00506948
Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD) No drug interventions treatment 2 terminated NCT06387082
A Clinical Study of HMPL-506 in Patients With Hematological Malignancies No drug interventions treatment 1 recruiting NCT02528682
MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT No drug interventions treatment 1 / 2 completed NCT01428973
Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens No drug interventions prevention 2 active_not_recruiting NCT01820962
Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients No drug interventions prevention 3 terminated NCT06258629
Prognostic Value of "CD200" in Hematological Malignancies. Hematological Malignancies Comprise a Group of Malignant Clonal Disorders Arising From the Hematopoietic Tissues , Including Leukemia , Multiple Myeloma , and They Have a High Morbidity and Mortality No drug interventions Not Available Not Available not_yet_recruiting NCT00047489
Study of ABT-751 in Patients With Refractory Hematologic Malignancies No drug interventions treatment 1 completed NCT02269592
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome No drug interventions Not Available Not Available recruiting NCT01235468
Allogenic Transplantation of Ex-vivo Expanded Cord Blood (CB) No drug interventions treatment 1 withdrawn NCT04184869
Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials No drug interventions treatment 1 completed NCT05338346
A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies No drug interventions treatment 1 terminated NCT01830010
A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies No drug interventions prevention 1 completed NCT02680795
Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes No drug interventions treatment 1 completed NCT05103995
Impact of Donor-recipient ABO Matching on Haploidentical Stem Cell Transplantation No drug interventions Not Available Not Available completed NCT03067155
CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation. No drug interventions treatment 2 completed NCT06584955
Feasibility of the Use of Weighted Blankets to Improve Sleep Among Patients with Hematological Malignancies No drug interventions supportive_care Not Available not_yet_recruiting NCT06224855
A Study of DXC006 in Patients With Advanced Solid Tumors and Hematologic Malignancies No drug interventions treatment 1 not_yet_recruiting NCT06225050
M-2018-334 in Hematological Malignancies No drug interventions treatment Not Available not_yet_recruiting NCT02859623
Descriptive Study of the Efficacy of Treatments for Blastic Dendritic Cell Neoplasm (BPDCN) No drug interventions Not Available Not Available completed NCT02459743
Molecular Disease Profile of Hematological Malignancies No drug interventions Not Available Not Available unknown_status NCT01166009
CIBMTR Research Database No drug interventions Not Available Not Available recruiting NCT02321345
Pretransplant Evaluation by Supportive Care Team for Patients Undergoing HCT for Hematological Malignancies No drug interventions supportive_care Not Available completed NCT03431090
Haploidentical Hematopoietic Cell Transplantation for Children With Hematologic Malignancies and Myelodysplasia No drug interventions treatment 1 / 2 active_not_recruiting NCT00333190
CD8+ T Cell Depletion for GVHD Prophylaxis After Peripheral Blood Stem Cell Transplantation No drug interventions prevention Not Available completed NCT02207764
Reiki as a Complementary Therapy: A Pilot Study No drug interventions supportive_care Not Available withdrawn NCT05787964
Immunity to Infection in Healthy Participants and Participants With Cancer No drug interventions Not Available Not Available active_not_recruiting NCT03795779
CLL1-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies No drug interventions treatment 0 unknown_status NCT05598879
Global Cardio Oncology Registry No drug interventions Not Available Not Available recruiting NCT00990587
Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy treatment 1 completed NCT05600933
Prospective Procurement of Tumor Tissue to Identify Novel Therapeutic Targets and Study the Tumor Microenvironment No drug interventions Not Available Not Available enrolling_by_invitation NCT05332054
Long-Term Follow-up Study No drug interventions Not Available Not Available enrolling_by_invitation NCT01554254
Evaluation of the Safety and Efficacy of TXA127 (Angiotensin 1-7) to Enhance Engraftment in Pediatric Patients Undergoing Single or Double Umbilical Cord Blood Transplantation treatment 2 withdrawn NCT05443854
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) No drug interventions treatment 3 unknown_status NCT03449953
Critical Care Outcomes of Hematologic Oncology Patients No drug interventions Not Available Not Available active_not_recruiting NCT04757545
Symptom Identification and Management in Patients With Hematological Malignancy During Follow-up Care No drug interventions supportive_care Not Available completed NCT00424645
Voraxaze for Delayed Methotrexate Clearance supportive_care 1 / 2 terminated NCT05779605
Telerehabilitation in Hemato-oncological Survivors No drug interventions supportive_care Not Available recruiting NCT04392128
Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE) treatment 2 withdrawn NCT04631211
Thrombosomes® in Bleeding Thrombocytopenic Patients Study treatment 2 terminated NCT06373471
Improving Quality of Life in Older Patients With Frailty and Hematological Cancer Through Geriatric Assessment No drug interventions treatment Not Available recruiting NCT03419078
Nutrition and Outcomes of Hematopoietic Cell Transplantation (HCT) No drug interventions Not Available Not Available completed NCT05216978
Proof-of-Concept Trial of a Positive Psychology Intervention for Caregivers of Patients Undergoing HSCT No drug interventions supportive_care Not Available completed NCT04156256
CD123-CD33 cCAR in Patients With Relapsed and/or Refractory, High Risk Hematologic Malignancies No drug interventions treatment 0 unknown_status NCT06401356
An Extension Study for Patients Previously Enrolled in Studies With Pelabresib treatment 3 not_yet_recruiting NCT04736056
Mindfulness and CBT for Sleep No drug interventions treatment Not Available completed NCT00504985
Fatigue in Emergency Center Patients No drug interventions Not Available Not Available terminated NCT03903185
Pharmacokinetics of Ledipasvir/Sofosbuvir in Hepatitis C Virus-Infected Children With Hematological Malignancy treatment 1 / 2 completed NCT03168815
Low-Flow vs. High-Flow Nasal Cannula for Hypoxemic Immunocompromised Patients During Diagnostic Bronchoscopy No drug interventions prevention Not Available active_not_recruiting NCT04537715
Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels treatment 1 completed NCT04889937
Usability, Adherence and Diagnostic Performance of PointCheck in Pediatric Population No drug interventions Not Available Not Available recruiting NCT04473937
Radiation Post-CAR T in Refractory Lymphoma No drug interventions treatment Not Available terminated NCT05397132
Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies No drug interventions Not Available Not Available recruiting NCT03992352
Composite Health Assessment Risk Model (CHARM) for Older Adults (BMT CTN 1704) No drug interventions Not Available Not Available completed NCT04496375
An Evaluation of Patients Access to Their Electronic Medical Records Via the IPC Connect Application No drug interventions Not Available Not Available unknown_status NCT05882175
Prospective Validation of the OHI Index No drug interventions Not Available Not Available recruiting NCT04136275
CAR-37 T Cells In Hematologic Malignancies No drug interventions treatment 1 completed NCT05968170
TCRαβ/CD19 Depletion of Stem Cell Grafts for Transplant No drug interventions treatment Not Available not_yet_recruiting NCT05476770
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies treatment 1 recruiting NCT02193399
Physiotherapy in Hematopoietic Stem Cell Transplantation No drug interventions treatment Not Available unknown_status NCT06018506
A Phase I Study of BR108 in Hematological Malignancies No drug interventions treatment 1 recruiting NCT02669706
Intravenous Pentamidine for Pneumocystis Jirovecii Pneumonia Not Available Not Available completed NCT03399149
Systematic Evaluation by an Intensivist of Hematological Malignancy Patients Presenting With Acute Respiratory or Hemodynamic Failure No drug interventions Not Available Not Available completed NCT06102213
Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation No drug interventions treatment 2 terminated NCT05716919
Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule treatment 1 active_not_recruiting NCT04628234
Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site (RESPECT) No drug interventions Not Available Not Available completed NCT05029024
Single Session of 30-Minute Mindful Breathing in Reducing Fatigue No drug interventions supportive_care Not Available completed NCT02049424
Observational Study in Patients Who Underwent an Haploidentical Transplantation With T-repleted Bone Marrow No drug interventions Not Available Not Available terminated NCT05708716
Diet and Cognitive Training in Hematologic Cancer Survivors No drug interventions supportive_care Not Available recruiting NCT06484816
TGRX-1942 Chinese Phase I for Advanced Solid Tumor and/or Relapsed/Refractory Hematologic Malignancies No drug interventions treatment 1 not_yet_recruiting NCT02041416
Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers No drug interventions Not Available Not Available active_not_recruiting NCT05164016
Evaluating Immune Response to COVID-19 Vaccines in Patients With Cancer, Transplant or Cellular Therapy Recipients No drug interventions Not Available Not Available recruiting NCT06278896
Early Neutropenic Fever De-escalation of Antibiotics Study No drug interventions treatment 3 not_yet_recruiting NCT02583035
Telephone OncoGériatric Followed in the Management of Elderly Patients Treated for Cancer or Haematological Malignancy No drug interventions other Not Available completed NCT06326463
CAR T-cell Therapy Directed to CD70 for Pediatric Patients With Hematological Malignancies treatment 1 recruiting NCT05509439
Home Transfusion for HEME No drug interventions health_services_research Not Available recruiting NCT06108739
ATG Plus Low-dose PT-Cy for GVHD Prevention treatment 3 recruiting NCT05400122
Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer treatment 1 recruiting NCT05038722
Function of Platelets Used for Transfusions No drug interventions Not Available Not Available enrolling_by_invitation NCT05690425
A Phase I Study of BC3402 as a Single Agent in Patients With MDS and CMML treatment 1 recruiting NCT05707325
Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies No drug interventions treatment 0 recruiting NCT06398457
Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies treatment 0 not_yet_recruiting NCT06410066
Outcomes of Critically Ill Patients With Hematologic Malignancies No drug interventions Not Available Not Available completed NCT04952766
Study Evaluating SARS-CoV-2 (COVID-19) Humoral Response After BNT162b2 Vaccine in Immunocompromised Adults Compared to Healthy Adults No drug interventions other 4 completed NCT06462365
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT) No drug interventions prevention 1 recruiting NCT04282174
CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies treatment 2 withdrawn NCT06206174
TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies No drug interventions treatment 1 / 2 recruiting NCT00165282
Mindfulness Meditation in Bone Marrow Transplantation No drug interventions Not Available 2 / 3 completed NCT03673631
Oxygenation Methods and Non-invasive Ventilation in Patients With Acute Respiratory Failure and a do Not Intubate Order No drug interventions Not Available Not Available unknown_status NCT05084027
Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT treatment 2 recruiting NCT05238376
Survivorship Post-HCT Optimization Program No drug interventions supportive_care Not Available recruiting NCT04892160
Distracting Through Procedural Pain and Distress No drug interventions supportive_care Not Available completed NCT05819762
Evaluation of ClearLLab LS Screening Panel No drug interventions Not Available Not Available recruiting NCT05250362
Ex Vivo Expanded NK Cells Infusion Decrease Relapse Post Hematopoietic Stem Cell Transplantation No drug interventions treatment 1 / 2 recruiting NCT04896580
IIT2020-20-SHIRAZIP-WALK: Nature Walks No drug interventions supportive_care Not Available active_not_recruiting NCT03717480
Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies No drug interventions treatment 2 terminated NCT04720144
Breakthrough Invasive Mold Infections Under Posaconazole Prophylaxis (BIMI) No drug interventions Not Available Not Available unknown_status NCT05046444
Solving Riddles Through Sequencing No drug interventions Not Available Not Available recruiting NCT05943067
CD45RA Depleted DLI After TCRα/β Depleted Haploidentical HCT No drug interventions treatment 1 / 2 recruiting NCT05887167
Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies No drug interventions treatment 1 recruiting NCT01341301
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies No drug interventions treatment 2 completed NCT01163201
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies No drug interventions treatment 1 / 2 withdrawn NCT00300001
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes No drug interventions Not Available Not Available unknown_status NCT05579769
A Phase II Pediatric Study of a Graft-VS.-Host Disease (GVHD) Prophylaxis Regimen With no Calcineurin Inhibitors After Day +60 Post First Allogeneic Hematopoietic Cell Transplant for Hematological Malignancies No drug interventions treatment 2 terminated NCT06579469
Prospective Evaluation Of Delayed Effects Of Pediatric Car T Cell Therapy No drug interventions Not Available Not Available not_yet_recruiting NCT04649112
Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies No drug interventions treatment 1 completed NCT01324310
Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer No drug interventions other 1 completed NCT04809181
Azacitidine in Combination With Venetoclax Treatment for MRD Positive Post Allo-HSCT AML/MDS Patients No drug interventions prevention 2 recruiting NCT01572181
Study of a Reduced-toxicity Myeloablative Conditioning Regimen Using Fludarabine and Full Doses of Intravenous Busulfan in Pediatric Patients Not Eligible for Standard Myeloablative Conditioning Regimens No drug interventions treatment 2 completed NCT05288595
TCR Alpha/Beta and CD19-deplete Haplo-HSCT No drug interventions treatment 2 not_yet_recruiting NCT03890614
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity No drug interventions Not Available Not Available recruiting NCT03149055
Fungal Prophylaxis With Isavuconazole for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (HCT) No drug interventions treatment 2 completed NCT02385955
Phase II Study of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adult Patients No drug interventions treatment 2 unknown_status NCT04847050
A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy No drug interventions prevention 2 completed NCT05158608
Comparison of PT-Cy at a Dose of 25 mg/kg/Day and PT-Cy at a Dose of 50 mg/kg/Day in GVHD Prophylaxis No drug interventions prevention 3 not_yet_recruiting NCT00840190
A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies No drug interventions treatment 1 completed NCT02612402
Effect of Smartphone App on Activity No drug interventions supportive_care Not Available unknown_status NCT05610202
Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects No drug interventions treatment 1 unknown_status NCT04684979
Transplantation of Hematopoietic Stem Cells From HLA-compatible Donors in Patients With B-Cell Lymphoid Malignancies No drug interventions treatment 2 withdrawn NCT05042479
Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology. No drug interventions supportive_care Not Available recruiting NCT04280133
CAR T-CELL Therapy Educational Video Trial No drug interventions supportive_care Not Available active_not_recruiting NCT06211751
A Clinical Trial of TQB3909 Tablets Combined With TQB3702 Tablets in Patients With Hematologic Malignancy No drug interventions treatment 1 not_yet_recruiting NCT03823651
A Research Program Targeting Pre- and Peri-transplant Optimization Program (R-PPOP) No drug interventions treatment Not Available unknown_status NCT05683353
Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors No drug interventions Not Available Not Available active_not_recruiting NCT00476177
Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant No drug interventions treatment 1 completed NCT06082947
αβT Cell/CD19+ B Cell Depletion for Alternative Donor Allogeneic Hematopoietic Cell Transplantation (HSCT) No drug interventions treatment Not Available recruiting NCT01839747
Evaluation of PET/MRI in Children With Cancer No drug interventions diagnostic Not Available unknown_status NCT06487247
HEME Home Transfusion Program No drug interventions supportive_care Not Available not_yet_recruiting NCT04776005
COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies No drug interventions Not Available Not Available recruiting NCT04690205
Hospital at Home at EOL in Heme Malignancies No drug interventions health_services_research Not Available completed NCT06153797
A Positive Psychology Based Intervention (PATH-C) for Caregivers of HSCT Survivors No drug interventions supportive_care Not Available recruiting NCT06416761
Genetics in the Progression of Nephropathies No drug interventions Not Available Not Available recruiting NCT04795128
A Study Evaluating the Safety, Tolerability and Preliminary Efficacy of IBI322 in Subjects With Hematologic Malignancy No drug interventions treatment 1 unknown_status NCT03135028
Entospletinib (ENTO) as Monotherapy and in Combination With Chemotherapy in Japanese Adults No drug interventions treatment 1 terminated NCT02880293
Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor No drug interventions treatment Not Available completed NCT05417971
Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical Transplantation No drug interventions Not Available Not Available recruiting NCT06208878
A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies No drug interventions Not Available Not Available enrolling_by_invitation NCT05384288
Response to Influenza Vaccination in Pediatric Oncology Patients No drug interventions Not Available Not Available recruiting NCT04944888
GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid Tumor No drug interventions treatment 1 completed NCT06001788
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia No drug interventions treatment 1 recruiting NCT04552288
Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies No drug interventions treatment 2 active_not_recruiting NCT05758207
Oral Complications in Hematological Malignancies No drug interventions Not Available Not Available recruiting NCT06130709
IRAF-ABLATION Study: a Multicenter International Retrospective Cohort of Patients With BTK Inhibitors-related AF Treated by Catheter Ablation No drug interventions Not Available Not Available not_yet_recruiting NCT06566209
FDG-PET As an Imaging Modality to Diagnose and Risk Stratify Subclinical, Imaging Negative Ici-Myocarditis No drug interventions Not Available Not Available not_yet_recruiting NCT03727009
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Hematologic Malignancies No drug interventions Not Available Not Available terminated NCT05413356
Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome No drug interventions treatment 2 recruiting NCT06415656
VitalTraq for the Detection of CRS No drug interventions diagnostic Not Available not_yet_recruiting NCT03373656
Vaccination for Children of H&O and Their Parents No drug interventions prevention Not Available recruiting NCT02668315
Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant No drug interventions treatment 1 / 2 completed NCT05284032
A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001) No drug interventions supportive_care 0 terminated NCT02711852
A Long-term, Continued Treatment and Follow-up Study in Participants With Hematologic Malignancies Treated With Duvelisib (IPI-145) No drug interventions treatment 2 completed NCT04707300
Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients with Hematologic Malignancies (HTLP-ONCO) No drug interventions treatment 1 / 2 recruiting NCT04673175
Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation No drug interventions treatment 1 / 2 recruiting NCT05355675
The Association of Microbiota Composition With cGVHD After Allo-HSCT No drug interventions Not Available Not Available recruiting NCT05860075
Exploratory Study of IMM01 for Injection in the Treatment of Refractory or Recurrent Hematologic Malignancy No drug interventions treatment 1 terminated NCT03459170
Safety/PK Study of Gene Modified Donor T Cell Infusion in Children With Recurrent Hem Malignancies After Allo Transplant No drug interventions treatment 1 active_not_recruiting NCT06252870
Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation No drug interventions treatment 2 recruiting NCT04425642
Effects of Parenteral Nutrition in HSCT No drug interventions treatment Not Available completed NCT05889806
AUD Biomarkers Study (Proteomic and Genomic Analysis of Biospecimens) No drug interventions Not Available Not Available enrolling_by_invitation NCT06528249
Safety, Tolerability and Preliminary Efficacy of Erythrocyte-αPD-1 Conjugate in Patients With Advanced Malignancies No drug interventions treatment 1 not_yet_recruiting NCT05921318
Beijing Protocol in Patients Receiving More Than 5/10 HLA-mismatched Allo-HSCT No drug interventions Not Available Not Available recruiting NCT05009719
Risk-adapted Donor Lymphocyte Infusion After Allo-HSCT in Children With Hematologic Malignancy No drug interventions prevention 1 / 2 completed NCT05735717
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies No drug interventions treatment 2 recruiting NCT05583734
A Prospective Study of Conventional Bone Marrow Biopsy Versus Portomar(TM) Biopsy No drug interventions diagnostic Not Available recruiting NCT02042924
Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies No drug interventions diagnostic Not Available terminated NCT04852796
Efficacy and Safety of the Anti- COVID-19 Vaccin in Clinical Hematology Patients No drug interventions Not Available Not Available completed NCT05463796
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer No drug interventions Not Available Not Available recruiting NCT02352558
A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies No drug interventions treatment 1 completed NCT00156858
Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study No drug interventions treatment Not Available unknown_status NCT04826458
Clinical Study Comparing Different Strategies to Increase Adherence to Oral Therapies in Oncohematology No drug interventions health_services_research Not Available unknown_status NCT03800758
Expressive Helping for Stem Cell Transplant Patients No drug interventions supportive_care 3 completed NCT01532635
A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives No drug interventions treatment 2 terminated NCT03986086
MPH966 for Prevention of Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions treatment 1 / 2 withdrawn NCT06582186
Individualized First Maintenance Doses of Voriconazole Through a Multiparametric Algorithm No drug interventions treatment 4 not_yet_recruiting NCT06449586
CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT No drug interventions prevention Not Available not_yet_recruiting NCT04395222
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation No drug interventions treatment 2 active_not_recruiting NCT04886622
A Study of DT2216 in Relapsed/Refractory Malignancies No drug interventions treatment 1 completed NCT02990130
Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available active_not_recruiting NCT05396157
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study No drug interventions Not Available Not Available active_not_recruiting NCT05820126
Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial No drug interventions treatment 2 not_yet_recruiting NCT04821466
VR for Symptom Control and Wellbeing No drug interventions supportive_care Not Available completed NCT00056966
Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases No drug interventions treatment 1 / 2 completed NCT05455866
Central Venous Catheter-related Complications in Patients Under Anticancer Treatment No drug interventions Not Available Not Available unknown_status NCT02512666
Non Invasive Optical Imaging of WBC Count No drug interventions device_feasibility Not Available completed NCT04509765
A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT No drug interventions treatment Not Available active_not_recruiting NCT04755465
Effects of NMES and Exercise in Hematological Cancer No drug interventions treatment Not Available completed NCT02134574
Prospective Cohort With Hemopathy in Languedoc-Roussillon No drug interventions Not Available Not Available recruiting NCT03133520
Effectiveness of High Flow Oxygen Therapy in Patients With Hematologic Malignancy Acute Hypoxemic Respiratory Failure No drug interventions treatment Not Available completed NCT03699631
PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant No drug interventions treatment 2 completed NCT06532773
Mindfulness Intervention for Sleep Disturbance and Symptom Management in Hematologic Cancer Patients During and After Inpatient Treatment No drug interventions treatment Not Available not_yet_recruiting NCT05609227
Effect of Mobile Application on Supportive Care Needs and Quality of Life Patients Undergoing Hematopoietic Stem Cell Transplantation No drug interventions supportive_care Not Available active_not_recruiting NCT02949427
The Oronasal Microbiota in Pediatric Oncology Patients No drug interventions Not Available Not Available completed NCT06350994
Early Assessment of Cardiac Function After Treatment With CAR-T Cells No drug interventions Not Available Not Available not_yet_recruiting NCT05063591
Removing Transfusion Dependence as a Barrier to Hospice Enrollment No drug interventions supportive_care Not Available active_not_recruiting NCT01846429
Oral Bicarbonate as Adjuvant for Pain Reduction in Patients With Tumor Related Pain No drug interventions supportive_care 1 terminated NCT05807789
Molecular-genetic Characterization in Patients Undergoing CAR-T Cell Infusion No drug interventions Not Available Not Available recruiting NCT06472089
BMT-CARE: Psychosocial Intervention for Transplant Caregivers No drug interventions supportive_care Not Available not_yet_recruiting NCT06541067
Study of Posaconazole Prophylaxis in Patients Receiving Hematopoietic Stem Cell Allograft (Allo-HSC) at High Risk of Invasive Fungal Infection (IFI) No drug interventions treatment 2 not_yet_recruiting NCT06131801
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution No drug interventions Not Available Not Available recruiting NCT05735704
Early Detection and Screening of Hematological Malignancies - SANGUINE No drug interventions Not Available Not Available recruiting NCT05529069
Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients No drug interventions treatment 2 recruiting NCT04827446
Lighting Intervention for Cancer-related Fatigue No drug interventions supportive_care Not Available completed NCT04710212
Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies No drug interventions Not Available Not Available completed NCT05709912
Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant No drug interventions supportive_care Not Available recruiting NCT05066412
Prophylactic CD45RA-depleted DLI After Haploidentical Transplantation/RIC No drug interventions treatment 1 not_yet_recruiting NCT01785810
Phase II Maraviroc for GVHD Prevention No drug interventions treatment 2 completed NCT01215981
Influenza Vaccine Post Allogeneic Transplant No drug interventions prevention Not Available terminated NCT04682314
B-Cell Reconstitution After Hematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available unknown_status NCT00673114
Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies No drug interventions treatment 1 / 2 completed NCT02718755
Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies No drug interventions treatment 2 withdrawn NCT05270655
Cognitive-behavioural Intervention for Anxiety, Depression and Quality of Life Among Children Receiving Chemotherapy. No drug interventions supportive_care Not Available completed NCT03555955
A Trial to Evaluate the Potential Impact of Renal Impairment on the Pharmacokinetics and Safety of CPX-351 No drug interventions treatment 1 completed NCT01324323
Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer No drug interventions other 1 completed NCT04454723
Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice No drug interventions supportive_care Not Available completed NCT02696408
Efficacy of Prophylactic Low Level Laser Therapy (LLLT) Performed by Nurses for Decreasing Severity of Oral Mucositis During Hematopoietic Stem Cell (HSC) Transplantation No drug interventions treatment 3 completed NCT05180838
Remote Temperature Data for Early Detection of Febrile Neutropenia No drug interventions Not Available Not Available active_not_recruiting NCT02359838
Patient-Centered Care for the Older Adult With Hematologic Malignancy No drug interventions other Not Available completed NCT04057443
Nutritional and Physical Exercise Intervention in Older Patients With Malignant Hemopathies No drug interventions supportive_care Not Available unknown_status NCT02304809
Phase 2 Study Assessing Secured Access to Vemurafenib for Patients With Tumors Harboring BRAF Genomic Alterations treatment 2 active_not_recruiting NCT01775072
Genomic Profiling in Cancer Patients No drug interventions Not Available Not Available recruiting NCT03512340
Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers No drug interventions treatment 1 completed NCT02034981
Phase 2 Study Assessing Efficacy and Safety of Crizotinib in Patients Harboring an Alteration on ALK, MET or ROS1 No drug interventions treatment 2 completed NCT03159702
Propylene Glycol-Free Melphalan HCl (EVOMELA®) in Combination With Fludarabine and Total Body Irradiation Based Reduced Intensity Conditioning for Haploidentical Transplantation No drug interventions treatment 2 recruiting NCT03771079
MS Detection of Somatic Mutations in Hematological Malignancies No drug interventions Not Available Not Available unknown_status NCT02906254
Early Antibiotic Discontinuation in FUO No drug interventions Not Available Not Available completed NCT04841447
Membrane Target Detection for Leukemia Treatment No drug interventions Not Available Not Available recruiting NCT03885947
VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies treatment 1 completed NCT01757145
Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation treatment 2 unknown_status NCT02562105
Prognosis of Hematological Cancer Patient Underwent Mechanical Ventillation No drug interventions Not Available Not Available completed NCT02880709
The Effect of Special Diets in Hematological Cancer Patients No drug interventions supportive_care 4 completed NCT06225856
An Open-Label, Multicenter, Phase I Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of YY201 in Patients With Advanced Solid Tumors and Hematological Malignancies No drug interventions treatment 1 recruiting NCT01719432
Effect of Body Mass on Filgrastim Pharmacokinetics No drug interventions Not Available Not Available completed NCT05828459
First-in-human Study of OT-A201 in Patients With Selected Hematological Malignancies and Solid Tumors treatment 1 recruiting NCT00558675
A Phase I/II Study of Mis-Matched Immune Cells (AlloStim) in Patients With Advanced Hematological Malignancy No drug interventions treatment 1 / 2 completed NCT05110742
Phase I/II Study of CD5 CAR Engineered IL15-Transduced Cord Blood-Derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapsed/Refractory Hematological Malignances treatment 1 / 2 recruiting NCT06584006
Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors treatment 2 recruiting NCT02534649
Bergonie Institut Profiling : Fighting Cancer by Matching Molecular Alterations and Drugs in Early Phase Trials No drug interventions diagnostic Not Available recruiting NCT06238336
Clinical Study of CAR-T Technology for the Treatment of Relapsed Refractory Malignant Haematological Tumours No drug interventions treatment 2 / 3 recruiting NCT04016116
Dual PD-1 and JAK2 Inhibition in Hematological Malignancies treatment 2 withdrawn NCT05537896
Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia treatment 2 recruiting NCT01853358
Phase I of Infusion of Selected Donor NK Cells After Allogeneic Stem Cell Transplantation No drug interventions treatment 1 completed NCT05391022
Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies treatment 1 completed NCT04093622
Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy No drug interventions Not Available Not Available terminated NCT05895357
The Effect of Music Therapy on Comfort, Pain and Anxiety No drug interventions supportive_care Not Available completed NCT04347226
Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19 No drug interventions treatment 2 terminated NCT03850366
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transplant Cyclophosphamide and Bortezomib treatment 2 recruiting NCT01317927
A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies treatment 1 completed NCT00897260
Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders No drug interventions treatment Not Available completed NCT05629260
The Optimization of Haploidentical Hematopoietic Stem Cell Transplantation Not Available Not Available recruiting NCT01714180
Effect of Body Mass on Acyclovir Pharmacokinetics No drug interventions Not Available Not Available completed NCT05293912
SG2501 Safety Study in Subjects With Relapsed or Refractory Hematological Malignancies and Lymphoma. No drug interventions treatment 1 recruiting NCT03806712
Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ) No drug interventions Not Available Not Available completed NCT04082910
Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells No drug interventions treatment 1 / 2 unknown_status NCT06066255
PROPHYLAXIS OF GVH IN ELDERLY PATIENTS RECEIVING HAPLOIDENTICAL ALLOGENIC HEMATOPOIETIC STEM CELL TRASNPLANTATION USE OF A LOW DOSE ANTI-LYMPHOCYTIC SERUM No drug interventions prevention 2 not_yet_recruiting NCT03241550
A Study of Intravenous and Oral Isavuconazonium Sulfate in Pediatric Patients No drug interventions treatment 1 completed NCT03611764
Body Scan Activity on Bone Marrow Transplant Patients and Their Caregivers No drug interventions supportive_care 1 terminated NCT00195533
Study Comparing Piperacillin-tazobactam Versus Piperacillin-tazobactam Plus Glycopeptide in Neutropenic Patients No drug interventions Not Available Not Available completed NCT01576653
Prospective Clinical Evaluation of Beta-D-Glucan Assay in Blood and BAL No drug interventions diagnostic Not Available completed NCT04287309
CAR-T Cellular Therapy for B Cell Malignancies Involved in CNS No drug interventions Not Available Not Available unknown_status NCT00149032
Treatment of Patients With Donor Lymphocytes Sensitized by Antigens Expressed by the Host No drug interventions treatment 2 withdrawn NCT02598752
Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation No drug interventions Not Available Not Available completed NCT06224452
Is Ibrutinib-related Atrial Fibrillation Dose Dependent No drug interventions Not Available Not Available not_yet_recruiting NCT01084252
Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies No drug interventions treatment 1 / 2 completed NCT05364359
Individual Dietary Counseling Based on Taste-tests in Patients With Hematological Cancer in Cytostatic Therapy No drug interventions other Not Available unknown_status NCT01860170
Post-Transplant Bortezomib and High Dose Cyclophosphamide as Graft-Versus-Host Disease (GVHD) Prophylaxis No drug interventions prevention 1 / 2 completed NCT05784870
A Study of Shengxuening Tablet in the Treatment of Chemotherapy-related Anemia in Hematologic Tumors No drug interventions treatment 3 recruiting NCT05467449
DxFLEX 10C Clinical Study No drug interventions Not Available Not Available completed NCT04305249
Safety and Preliminary Efficacy of ATG-017 Monotherapy or Combination Therapy With Nivolumab in Advanced Solid Tumors and Hematological Malignancies No drug interventions treatment 1 terminated NCT00894049
A Study Comparing Non Myeloablative (Flu-TBI) and Reduced Intensity (FLU-BU-ATG) Conditioning in Allogenic Transplantation No drug interventions treatment 2 completed NCT01086735
Suicide Gene Therapy for Donor Lymphocytes Infusion After Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions treatment 1 / 2 completed NCT02372357
A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area No drug interventions prevention 4 completed NCT05255926
CXCR4-targeted PET/CT Imaging in Hematological Malignancies No drug interventions diagnostic Not Available recruiting NCT04613765
A Mixed Method to Study Adherence to Oral Anticancer Medications in a Multilingual and Multicultural Setting No drug interventions Not Available Not Available unknown_status NCT04687982
Feasibility and Efficacy of Modified Donor Lymphocytes Infusion (CD45RA Negative Selected) After Haploidentical Transplantation With Post-transplantation Cyclophosphamide in Patients With Hematological Malignancies (ONC-2016-002). No drug interventions prevention Not Available completed NCT06106360
A Pilot Prospective Clinical Trial Using Remote Monitoring for Cancer Patients Undergoing Outpatient Chemotherapy No drug interventions Not Available Not Available recruiting NCT02828462
Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics No drug interventions Not Available Not Available unknown_status NCT02149329
Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO No drug interventions treatment 4 completed NCT05510089
Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies No drug interventions treatment Not Available recruiting NCT04932967
Use of nMoABs for the Treatment of COVID-19 in Patients With HM. No drug interventions Not Available Not Available completed NCT04884204
Systematic Symptom Identification With Disease Specific PROM to Assess Symptoms of Chronic GVHD in Outpatient Care in Patients Post HSCT No drug interventions supportive_care Not Available completed NCT02900768
Effects of Exercise on Allogeneic Stem Cell Transplant No drug interventions supportive_care Not Available unknown_status NCT05768269
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product No drug interventions Not Available Not Available recruiting NCT00893555
Pharmacologic Optimization of Voriconazole No drug interventions treatment 3 completed NCT04684108
SG301 Safety Study in Subjects With Relapsed or Refractory Multiple Myeloma and Other Hematological Malignancies No drug interventions treatment 1 active_not_recruiting NCT03469921
Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016 No drug interventions Not Available Not Available completed NCT03541330
Information and Accompaniment of Siblings Following the Announcement of a Cancer in Pediatric Hematology. No drug interventions other Not Available recruiting NCT01574235
Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents Not Available Not Available completed NCT00190463
Comparison of 2 Antifungal Treatment (Empirical Versus Pre-Empirical) Strategies in Prolonged Neutropenia treatment 4 terminated NCT04390126
COVID-19 Related Lockdown Effects On Chronic Diseases No drug interventions Not Available Not Available unknown_status NCT03965429
Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation No drug interventions Not Available Not Available recruiting NCT04517656
Biomarkers Impact Evaluation on the Post-transplant Immune Response After Allografting of Hematopoietic Stem Cells No drug interventions prevention Not Available recruiting NCT02999152
Validation of Radio-induced Damage Biomarkers No drug interventions prevention Not Available terminated NCT02140736
Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology No drug interventions Not Available Not Available completed